We are international
Donate
• about myeloma TEXT SIZE   
publications    back

REVLIMID® EXTENDS SURVIVAL WITH POSITIVE IMPLICATIONS FOR A WIDE RANGE OF BLOOD CANCERS
Two Studies in the Prestigious New England Journal of Medicine Validate the Findings.
11.22.07

Be the first to comment

 related articles